M&A Deal Summary

Argentum Capital Partners and First Analysis Acquire QPS

On March 3, 2008, growth capital firm Argentum Capital Partners and venture capital firm First Analysis acquired life science company QPS

Acquisition Highlights
  • This is Argentum Capital Partners’ 2nd and First Analysis’ 2nd transaction in the Life Science sector.
  • This is Argentum Capital Partners’ 14th and First Analysis’ 26th transaction in the United States.
  • This is Argentum Capital Partners’ 1st and First Analysis’ 1st transaction in Delaware.

M&A Deal Summary

Date 2008-03-03
Target QPS
Sector Life Science
Buyer(s) Argentum Capital Partners
First Analysis
Deal Type Buyout (LBO, MBO, MBI)

Target

QPS

Newark, Delaware, United States
website
QPS provides GLP/GCP-compliant preclinical and clinical research services to pharmaceutical and biotechnology clients worldwide in the areas of Bioanalysis, Drug Metabolism and Pharmacokinetics, Toxicology, Translational Medicine, and Clinical Research. QPS was established in 1995 and is based in Newark, Delaware.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Argentum Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 1988
PE ASSETS 400M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Argentum Capital Partners is a private equity firm focused on investing in small to mid-sized companies with proven business models and the ability to become market leaders. Prospective transaction situations include growth capital financing, management buyouts, platform acquisitions, and recapitalization. The firm typically takes minority positions, except in the case of management buyouts. Industry sectors of interest include business services, healthcare, and technology. Argentum generally prefers opportunities located in the Eastern US, but will consider companies across the US. Argentum Capital Partners was formed in 1988 and is based in New York City.


DEAL STATS #
Overall 16 of 43
Sector (Life Science) 2 of 2
Type (Buyout (LBO, MBO, MBI)) 9 of 10
State (Delaware) 1 of 1
Country (United States) 14 of 40
Year (2008) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-12 ReSearch Pharmaceutical Services

Fort Washington, Pennsylvania, United States

ReSearch Pharmaceutical Services, Inc. is a provider of integrated global clinical development solutions to the bio-pharmaceutical industry based on its comprehensive therapeutic expertise, robust clinical operations infrastructure, and highly trained and experienced employee base.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-29 NuCO2

Stuart, Florida, United States

NuCo2 is a supplier of liquid carbon dioxide (as opposed to carbon dioxide gas in cylinders) to retail establishments for carbonating and dispensing fountain beverages. It is also the only national supplier to this essentially noncyclical U.S. market.

Sell -
Buyer

First Analysis

Chicago, Illinois, United States

Investor Investor Investor Investor Investor

website


Category Venture Capital Firm
Founded 1981
PE ASSETS 800M USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

First Analysis is a financial advisory and investment firm. First Analysis' private equity arm targets investments in growth companies at all stages of development. The Group looks for opportunities based primarily in the US and can commit up to $10 million of equity per transaction. Sectors of particular interest include outsourced services, (business/government services, education, environmental services, healthcare services, marketing services); information technology, (business integration, call centers, healthcare IT, network security, open source, sensor systems, transaction processing); and chemistry enabled businesses (advanced materials, chemicals, healthcare products, polymers, purification). First Analysis was formed in 1981 and is based in Chicago, Illinois.


DEAL STATS #
Overall 27 of 60
Sector (Life Science) 2 of 3
Type (Buyout (LBO, MBO, MBI)) 11 of 11
State (Delaware) 1 of 1
Country (United States) 26 of 57
Year (2008) 4 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-12 ReSearch Pharmaceutical Services

Fort Washington, Pennsylvania, United States

ReSearch Pharmaceutical Services, Inc. is a provider of integrated global clinical development solutions to the bio-pharmaceutical industry based on its comprehensive therapeutic expertise, robust clinical operations infrastructure, and highly trained and experienced employee base.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-29 NuCO2

Stuart, Florida, United States

NuCo2 is a supplier of liquid carbon dioxide (as opposed to carbon dioxide gas in cylinders) to retail establishments for carbonating and dispensing fountain beverages. It is also the only national supplier to this essentially noncyclical U.S. market.

Sell -